Description

Teijin Limited, a Japanese conglomerate established in Tokyo in 1918, operates on a global scale across diverse sectors. Its core businesses encompass advanced materials, including fibers, films and sheets, and composites, as well as significant operations in healthcare and information technology. The company's materials division provides a comprehensive range of products such as high-performance aramid, carbon, and oxidized PAN fibers, along with various polyethylene materials. This segment also offers specialized items like polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. Its offerings extend to polycarbonate, high-density polyethylene porous, and microporous films and sheets, in addition to PC and polyphenylene sulfide resins, molded parts, and additives. Teijin is also a specialist in composite materials, notably developing lightweight glass and carbon fiber reinforced solutions designed for the automotive industry. In the healthcare sector, Teijin develops pharmaceuticals aimed at treating bone and joint, respiratory, and cardiovascular and metabolic diseases, among others. Furthermore, it supplies an extensive array of medical devices and services, including home oxygen therapy equipment, non-invasive positive pressure ventilation systems, rehabilitation tools, and devices for sleep-disordered breathing. The company also provides a sonic accelerated fracture healing system, community-based integrated care systems, orthopedic implantable devices, and functional food ingredients. Within its IT operations, Teijin offers innovative solutions such as Recopic, a radio-frequency identification (RFID) technology tailored for efficient inventory management. Beyond its product lines, the company is actively involved in engineering solutions, tackling critical global challenges related to environmental pollution, ensuring energy supply stability, and addressing the impact of an aging workforce population.